History, current situation and bottleneck of the diagnosis and treatment system of hepatic hilar cholangiocarcinoma in Japan
10.3760/cma.j.issn.0529-5815.2019.01.002
- VernacularTitle: 肝门部胆管癌日本诊治体系的历史沿革、现状和瓶颈
- Author:
Di ZHOU
1
;
Yong YANG
;
Zhaohui TANG
;
Wei GONG
;
Jiandong WANG
;
Zhiwei QUAN
Author Information
1. Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200092, China
- Publication Type:Journal Article
- Keywords:
Bile duct neoplasms;
Embolization, therapeutic;
Hilar cholangiocarcinoma;
Perioperative treatment
- From:
Chinese Journal of Surgery
2019;57(1):6-9
- CountryChina
- Language:Chinese
-
Abstract:
Hilar cholangiocarcinoma is one of the most difficult malignant tumors to treat in the biliary system. In Japan, 5-year survival rate of the disease has increased from 32.5% to 67.1% during the past 30 years. The impressive progress reflects the solid efforts in preoperative endoscopic diagnosis, innovation in surgery such as PTPE as well as hepato-pancreatoduodenectomy and perioperative treatment including replacement of the bile and synbiotic treatment, which have finally formed a set of standardized diagnosis and treatment systems. The present review intends to report the history, current status and remaining bottlenecks of the diagnosis and treatment system of hilar cholangiocarcinoma in Japan as follows.
